Skip to main content

Krisztina Holly, Kathryn Atchison, Raymond Arner, Anne Marie Cook, Senator Max Baucus, Sharon Peterson

Premium
Entretech, a business development organization supporting high-tech companies throughout Greater Los Angeles, last week said that it has appointed two new board members: Krisztina Holly, vice provost and executive director of the University of Southern California Stevens Institute for Innovation; and Kathryn Atchison, vice provost of intellectual property and industry relations, and associate vice chancellor for research at University of California, Los Angeles. Holly and Athcison join 10 other board members.
 

 
Miller, Canfield, Paddock, and Stone, PLC, Michigan’s largest corporate law firm, last week said that it will open an office in Cambridge, Mass., to expand its work in biotechnology, life sciences, intellectual property, and venture and technology.
 
The new office will be located at One Broadway in Cambridge’s Kendall Square. Leading the office in Cambridge are Raymond Arner, former senior vice president and chief IP counsel at Biogen Idec; and Anne Marie Cook, senior vice president, business and corporate development, general counsel, and secretary of ViaCell.
 

 
The Biotechnology Industry Organization last week said that it has selected Senator Max Baucus (D-Mont.) as legislator of the year for 2006-2007.
 
Senator Baucus received the award from Sharon Peterson, executive director of Montana BioScience Alliance.
 
“Senator Baucus has been a strong proponent of the biotechnology industry and … has been a champion of the federal research and development tax credit and recently introduced the Research Competitiveness Act of 2007,” Jim Greenwood, BIO president and CEO, said in a statement.

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.